CVS Caremark Corporation (CVS) Posts Q2 EPS of $0.65, Shy of Views; Guides SSS Lower; Sees FY10 EPS Lower
CVS Hot Sheet
Revenue Growth %: +18.9%Financial Fact:
Net income: 775M
Today's EPS Names:
TARO, BRLI, TLB, More
CVS Caremark Corporation (NYSE: CVS) reports Q2 EPS of $0.65, versus the analyst estimate of $0.68. Revenue for the quarter was $24 billion, which compares to the estimate of $24.13 billion.
Lowers FY10 EPS from $2.77 - 2.84 to $2.68 - $2.73. Consensus sees an EPS of $2.79.
SSS outlook from 3.5% - 5.5% to 2.0% - 3.5% growth.
Lowers FY10 EPS from $2.77 - 2.84 to $2.68 - $2.73. Consensus sees an EPS of $2.79.
SSS outlook from 3.5% - 5.5% to 2.0% - 3.5% growth.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
